Colombia’s Superintendence for Industry and Commerce (SIC) has issued a fine to Chilean drug-store chain Cruz Verde after the company jacke dup the price of 56 separate medications by up to 3000%, far beyond the maximum prices set by the country’s authorities.
Colombian authorities settled on fines for Cruz Verde totalling approximately $84,500 USD. Colombian media has reported that the pharmacy has already begun the process of appealing the fine, arguing that their chain has always respected the price limits set forth by the country’s guidelines.
Cruz Verde was embroiled in a similar price-fixing scheme in Chile between 2007 and 2008 in conjunction with fellow drug-store chains Farmacias Ahumada and Salcobrand, with the firm paying a total of 13 million pesos to Chile’s government.
Full Content: El Ciudadano
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Belgian Authorities Detain Multiple Individuals Over Alleged Huawei Bribery in EU Parliament
Mar 13, 2025 by
CPI
Grubhub’s Antitrust Case to Proceed in Federal Court, Second Circuit Rules
Mar 13, 2025 by
CPI
Pharma Giants Mallinckrodt and Endo to Merge in Multi-Billion-Dollar Deal
Mar 13, 2025 by
CPI
FTC Targets Meta’s Market Power, Calls Zuckerberg to Testify
Mar 13, 2025 by
CPI
French Watchdog Approves Carrefour’s Expansion, Orders Store Sell-Off
Mar 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Self-Preferencing
Feb 26, 2025 by
CPI
Platform Self-Preferencing: Focusing the Policy Debate
Feb 26, 2025 by
Michael Katz
Weaponized Opacity: Self-Preferencing in Digital Audience Measurement
Feb 26, 2025 by
Thomas Hoppner & Philipp Westerhoff
Self-Preferencing: An Economic Literature-Based Assessment Advocating a Case-By-Case Approach and Compliance Requirements
Feb 26, 2025 by
Patrice Bougette & Frederic Marty
Self-Preferencing in Adjacent Markets
Feb 26, 2025 by
Muxin Li